Viewing Study NCT00871169


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT00871169
Status: COMPLETED
Last Update Posted: 2016-06-14
First Post: 2009-03-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: New Mexico Cancer Research Alliance
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Irinotecan View
None Oxaliplatin View
None Cetuximab View
None Advanced or metastatic pancreatic cancer View